Beyond the symptom: the biology of fatigue

A workshop titled "Beyond the Symptom: The Biology of Fatigue" was held virtually September 27-28, 2021. It was jointly organized by the Sleep Research Society and the Neurobiology of Fatigue Working Group of the NIH Blueprint Neuroscience Research Program. For access to the presentations and video recordings, see: https://neuroscienceblueprint.nih.gov/about/event/beyond-symptom-biology-fatigue. The goals of this workshop were to bring together clinicians and scientists who use a variety of research approaches to understand fatigue in multiple conditions and to identify key gaps in our understanding of the biology of fatigue. This workshop summary distills key issues discussed in this workshop and provides a list of promising directions for future research on this topic. We do not attempt to provide a comprehensive review of the state of our understanding of fatigue, nor to provide a comprehensive reprise of the many excellent presentations. Rather, our goal is to highlight key advances and to focus on questions and future approaches to answering them.

The preliminary effects of moderate aerobic training on cognitive function in people with TBI and significant memory impairment: a proof-of-concept randomized controlled trial

This single-blinded RCT investigated cognitive effects of aerobic exercise in persons with TBI-related memory impairment. Five participants . were randomly assigned to 12-weeks of either supervised moderate intensity aerobic cycling or an active control. Outcome measures included neuropsychological assessments and structural neuroimaging (MRI,). The exercise group demonstrated greater improvements on auditory verbal learning (RAVLT; d=1.54) and processing speed (SDMT; d=1.58). The exercise group showed larger increases in volume of the left hippocampus (d=1.49) and right thalamus (d=1.44). These pilot data suggest that 12-weeks of moderate intensity aerobic cycling may improve memory and processing speed in those with TBI-related memory impairments.

Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination

This is a case of symmetrical drug-related intertriginous and flexural exanthema-like eruption following ChAdOx1 nCoV-19 (AstraZeneca-Oxford) vaccination. Investigations, including repeated skin swabs, ruled out an infectious cause. He was subsequently treated with oral prednisolone, which led to a resolution of his symptoms.

The impact of level of injury on patterns of cognitive dysfunction in individuals with spinal cord injury

Context: While it is well recognized that physical and physiological changes are more prominent in individuals with higher neurologic levels of spinal cord injury (SCI), the impact of level of lesion on cognition is less clear. Design: Cross-sectional, 3-group. Setting: Non-profit rehabilitation research foundation. Participants: 59 individuals with SCI (30 with tetraplegia, 29 with paraplegia) and 30 age-matched healthy controls (HC). Interventions: None. Outcome Measures: Neuropsychological tests in the domains of attention, working memory, processing speed, executive control, and learning and memory. Results: Results indicated significantly lower test performance in individuals with paraplegia on new learning and memory testing compared to HC. In contrast, compared to HC the group with tetraplegia, showed a significantly impaired performance on a processing speed task, and both the tetraplegia and the paraplegia groups were similarly impaired on a verbal fluency measure. SCI groups did not differ on any cognitive measure. Conclusion: Individuals with SCI may display different patterns of cognitive performance based on their level of injury.

Changes in plant function and root mycobiome caused by flood and drought in a riparian tree

Under increasingly harsh climatic conditions, conservation of threatened species requires integrative studies to understand stress tolerance. Riparian Ulmus minor Mill. populations have been massively reduced by Dutch Elm disease (DED). However, resistant genotypes were selected to restore lost populations. To understand the acclimation mechanisms to the succession of abiotic stresses, ramets of five DED-tolerant U. minor genotypes were subjected to flood and subsequently to drought. Physiological and biochemical responses were evaluated together with shifts in root-fungal assemblages. During both stresses, plants exhibited a decline in leaf net photosynthesis and an increase in percentage loss of stem hydraulic conductivity and in leaf and root proline content. Stomatal closure was produced by chemical signals during flood and hydraulic signals during drought. Despite broad similarities in plant response to both stresses, root-mycobiome shifts were markedly different. The five genotypes were similarly tolerant to moderate drought, however, flood tolerance varied between genotypes. In general, flood did not enhance drought susceptibility due to fast flood recovery, nevertheless, different responses to drought after flood were observed between genotypes. Associations were found between some fungal taxonomic groups and plant functional traits varying with flood and drought (e.g. proline, chlorophyll and starch content) indicating that the thriving of certain taxa depends on host responses to abiotic stress.

The Role of Premotor Areas in Dual Tasking in Healthy Controls and Persons With Multiple Sclerosis: An fNIRS Imaging Study

Persons with multiple sclerosis (pwMS) experience declines in physical and cognitive abilities and are challenged by dual-tasks. Dual-tasking causes a drop in performance, or what is known as dual-task cost (DTC). This study examined DTC of walking speed (WS) and cognitive performance (CP) in pwMS and healthy controls (HCs) and the effect of dual-tasking on cortical activation of bilateral premotor cortices (PMC) and bilateral supplementary motor area (SMA). Fourteen pwMS and 14 HCs performed three experimental tasks: (1) single cognitive task while standing (SingCog); (2) single walking task (SingWalk); and (3) dual-task (DualT) that included concurrent performance of the SingCog and SingWalk. Six trials were collected for each condition and included measures of cortical activation, WS and CP. WS of pwMS was significantly lower than HC, but neuropsychological (NP) measures were not significantly different. pwMS and HC groups had similar DTC of WS, while DTC of CP was only significant in the MS group; processing speed and visual memory predicted 55% of this DTC. DualT vs. SingWalk recruited more right-PMC activation only in HCs and was associated with better processing speed. DualT vs. SingCog recruited more right-PMC activation and bilateral-SMA activation in both HC and pwMS. Lower baseline WS and worse processing speed measures in pwMS predicted higher recruitment of right-SMA (rSMA) activation suggesting maladaptive recruitment. Lack of significant difference in NP measures between groups does not rule out the influence of cognitive factors on dual-tasking performance and cortical activations in pwMS, which might have a negative impact on quality of life.

Patterns of cognitive deficits in persons with spinal cord injury as compared with both age-matched and older individuals without spinal cord injury

Context/Objective: Cognitive deficits can impact as many as 60% of individuals with spinal cord injury (SCI). In an effort to identify the nature of cognitive deficits in SCI, we examined neuropsychological test performance in individuals with SCI, age matched healthy controls and older healthy controls.Design: Participants completed a motor-free neuropsychological test battery assessing attention, working memory, information processing speed, new learning /memory and executive control.Setting: Outpatient rehabilitation research facility.Participants: Participants included 60 individuals with chronic spinal cord injury [SCI; 32 with paraplegia (T2-T12) and 28 with tetraplegia (C3-T1)], 30 age-matched healthy controls (AMHC; 30-40 years old) and 20 older healthy controls (OHC; 50-60 years old).Outcome Measures: Wechsler Intelligence Scale - 3^rd edition (WAIS-III) Digit Span and Letter-Number Sequencing; Symbol Digit Modalities Test (SDMT) - oral version; California Verbal Learning Test-II; Paced Auditory Serial Addition Test (PASAT); Wechsler Abbreviated Scale of Intelligence (WASI); Delis-Kaplan Executive Function System; Verbal Fluency subtest.Results: Significant differences were noted between the SCI and AMHC groups on measures of information processing speed, new learning and memory, and verbal fluency. No significant differences were noted between the groups on tests of attention or working memory.Conclusion: The current study documented differences in specific realms of cognitive functioning between a chronic SCI sample and AMHC. Implications for cognitive rehabilitation and overall quality of life are discussed. Additional research is needed utilizing a more comprehensive battery of motor-free neuropsychological tests that avoid the confound of upper limb motor limitations on cognitive performance.

Neuroimaging and cognition using functional near infrared spectroscopy (fNIRS) in multiple sclerosis

The present study utilized functional near infrared spectroscopy (fNIRS) to detect neural activation differences in the orbitofrontal brain region between individuals with multiple sclerosis (MS) and healthy controls (HCs) during a working memory (WM) task. Thirteen individuals with MS and 12 HCs underwent fNIRS recording while performing the n-back WM task with four levels of difficulty (0-, 1-, 2-, and 3-back). Subjects were fitted with the fNIRS cap consisting of 30 'optodes' positioned over the forehead. The results revealed different patterns of brain activation in MS and HCs. The MS group showed an increase in brain activation, as measured by the concentration of oxygenated hemoglobin (oxyHb), in the left superior frontal gyrus (LSFG) at lower task difficulty levels (i.e. 1-back), followed by a decrease at higher task difficulty (2- and 3-back) as compared with the HC group. HC group achieved higher accuracy than the MS group on the lower task loads (i.e. 0- and 1-back), however there were no performance differences between the groups at the higher task loads (i.e. 2- and 3-back). Taken together, the results suggest that individuals with MS experience a task with the lower cognitive load as more difficult than the HC group, and the brain activation patterns observed during the task confirm some of the previous findings from functional magnetic resonance imaging (fMRI) studies. This study is the first to investigate brain activation by utilizing the method of fNIRS in MS during the performance of a cognitive task.

Subjective cognitive fatigue in multiple sclerosis depends on task length

Objective: The objective of this paper is to investigate the interrelationship between subjective and objective cognitive fatigue, information processing domain [processing speed (PS) vs. working memory (WM)], cognitive load (high vs. low), and time on task in Multiple Sclerosis (MS).

Methods: Thirty-two MS participants and 24 healthy controls completed experimental tasks in both the PS and WM domains with different levels of cognitive load. Subjective cognitive fatigue was measured using a visual analog scale at baseline and at multiple time points throughout the experiment.

Results: A mixed model ANOVA revealed that subjective cognitive fatigue was higher for the PS task, increased across time, and was higher in the MS group. These findings were qualified by an interaction demonstrating that the MS group showed a steeper increase in subjective cognitive fatigue over time than the healthy control group. Subjective and objective (i.e., performance) cognitive fatigue were not correlated.

Conclusion: In this study, subjective and objective cognitive fatigue appears to be independent and cognitive fatigue does not depend on cognitive load. Subjective cognitive fatigue increased with time on task and subjective cognitive fatigue increased more steeply for the MS group. These data suggest that cognitive fatigue in MS is a function of time, that is, the longer participants were engaged in a cognitive task, the more likely it was for them to report increases in cognitive fatigue.

Does slowed processing speed account for executive deficits in multiple sclerosis? Evidence from neuropsychological performance and structural neuroimaging

OBJECTIVE

Executive deficits and slow processing speed (PS) are observed in persons with multiple sclerosis (MS). The question of whether executive deficits can be explained by slow PS was examined with neuropsychological measures and a neurostructural measure (brain atrophy).

METHOD

Fifty MS patients were compared with 28 healthy controls (HCs) on tasks of executive functioning with and without a PS element (e.g., Trail Making Test and Wisconsin Card Sorting Test).

RESULTS

The MS group performed worse than HCs on speeded tasks of executive function. However, after controlling for speed, group differences on executive tasks disappeared. There were also no group differences on executive tasks with no PS demands. The effect of disease progression on executive task performance was assessed in the MS group. Higher atrophy in MS participants was associated with greater deficits on speeded executive tasks, but this association disappeared when controlling for PS. There was no association between atrophy and performance on nonspeeded executive tasks.

CONCLUSIONS

Our results support the notion that executive deficits in MS may be explained by slow PS. These findings highlight the role of slowed PS as a primary impairment underlying other cognitive functions. Disentangling the relative contribution of PS to executive function is an important step toward the development of appropriate rehabilitation strategies for persons with MS.

Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging

The present study investigated the neural correlates of cognitive fatigue in Multiple Sclerosis (MS), looking specifically at the relationship between self-reported fatigue and objective measures of cognitive fatigue. In Experiment 1, functional magnetic resonance imaging (fMRI) was used to examine where in the brain BOLD activity covaried with “state” fatigue, assessed during performance of a task designed to induce cognitive fatigue while in the scanner. In Experiment 2, diffusion tensor imaging (DTI) was used to examine where in the brain white matter damage correlated with increased “trait” fatigue in individuals with MS, assessed by the Fatigue Severity Scale (FSS) completed outside the scanning session. During the cognitively fatiguing task, the MS group had increased brain activity associated with fatigue in the caudate as compared with HCs. DTI findings revealed that reduced fractional anisotropy in the anterior internal capsule was associated with increased self-reported fatigue on the FSS. Results are discussed in terms of identifying a “fatigue-network” in MS.

The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis

The primary purpose of the current study was to examine the relationship between performance on executive tasks and white matter integrity, assessed by diffusion tensor imaging (DTI) in multiple sclerosis (MS). A second aim was to examine how processing speed affects the relationship between executive functioning and fractional anisotropy (FA). This relationship was examined in two executive tasks that rely heavily on processing speed: the Color-Word Interference Test and the Trail Making Test (Delis-Kaplan Executive Function System). It was hypothesized that reduced FA is related to poor performance on executive tasks in MS, but that this relationship would be affected by the statistical correction of processing speed from the executive tasks. A total of 15 healthy controls and 25 persons with MS participated. Regression analyses were used to examine the relationship between executive functioning and FA, both before and after processing speed was removed from the executive scores. Before processing speed was removed from the executive scores, reduced FA was associated with poor performance on the Color-Word Interference Test and Trail Making Test in a diffuse network including corpus callosum and superior longitudinal fasciculus. However, once processing speed was removed, the relationship between executive functions and FA was no longer significant on the Trail Making Test, and significantly reduced and more localized on the Color-Word Interference Test.

Increased cerebral activation after behavioral treatment for memory deficits in MS

Deficits in new learning and memory are common in persons with multiple sclerosis (MS), though few studies have examined the efficacy of memory retraining in MS. Previous research from our laboratory has demonstrated that the modified Story Memory Technique (mSMT) significantly improves new learning and memory in MS. The present double-blind, placebo-controlled, randomized clinical trial was designed to examine changes in cerebral activation following mSMT treatment. Sixteen individuals with clinically definite MS were randomly assigned to treatment (n = 8) or placebo-control (n = 8) groups, matched for age, education, and disease characteristics. Baseline and follow-up fMRI was collected during performance of learning and memory tasks. No baseline activation differences on fMRI were seen between groups. After treatment, greater activation was evident in the treatment group during performance of a memory task within a widespread cortical network involving frontal, parietal, precuneus, and parahippocampal regions. All participants in the treatment group showed increased activation in frontal and temporal regions in particular. In contrast, the control group showed no significant changes in cerebral activation at follow-up. A significant association was found between increased activation in the right middle frontal gyrus and improved memory performance post-treatment. The increased activation seen likely reflects increased use of strategies taught during treatment when learning new information. This study is the first to demonstrate a significant change in cerebral activation resulting from a behavioral memory intervention in an MS sample. Behavioral interventions can show significant changes in the brain, validating clinical utility.

Altered effective connectivity during performance of an information processing speed task in multiple sclerosis

Background: Functional magnetic resonance imaging (fMRI) studies of persons with multiple sclerosis (MS) reveal distinct patterns of activation during task performance. We were interested in determining whether distinct patterns of effective connectivity would be revealed with Granger causality analysis (GCA).

Objective: To characterize directed neural connections in persons with MS during a processing speed task between brain regions known to be activated in healthy controls.

Methods: fMRI and GCA were used to examine effective connectivity underlying performance of a processing speed task in persons with MS. In total, 16 individuals with MS and 17 healthy controls (HC) performed a modified version of the Symbol Digit Modality Task (mSDMT) in the MRI scanner. Eight seed regions were selected on the basis of a priori data showing areas involved in mSDMT performance of HC.

Results: Behaviorally, the MS group attained a level of accuracy equivalent to the HC group, although they were significantly slower. While there was a great deal of overlap in the connections relied upon by both groups, the MS group showed significant differences in connectivity between critical brain regions. Specifically, the MS group had more connections from multiple regions to frontal cortices bilaterally relative to HCs.

Conclusions: Greater neural recruitment by the MS group relative to HC is consistent with the neural efficiency hypothesis, and lends further support to the notion that more connections must be recruited to maintain performance in the presence of brain pathology.

Effect of withdrawing topical fusidic acid on Staphylococcus aureus resistance rates

A previous local study revealed high levels of fusidic acid (FA) resistance within dermatology. It was therefore decided to limit use of topical FA within dermatology and then assess the effect on resistance rates. The local microbiology department produced FA resistance data within dermatology over a five-year period. This was then compared with data provided for four other control specialties. Since withdrawal of FA in dermatology, between 2002 and 2006, there was a statistically significant fall in FA resistance rates, while the other four control specialty areas showed increases in resistance rates. In conclusion, it would appear that, in dermatology, withdrawal of topical FA could have a beneficial effect on overall resistance rates for this antibiotic. Given these findings, we made recommendations that other local dermatology units consider their policy on the routine use of topical fusidic preparations.

Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI

Although fatigue is one of the major symptoms of persons with multiple sclerosis (MS), the behavioral and neural correlates are poorly understood. The present study utilized a novel approach to cognitive fatigue examining objective behavioral performance while simultaneously monitoring brain activity using fMRI. Fifteen persons with MS and 15 healthy controls were given 4 trials of a behavioral task assessing processing speed (mSDMT) during fMRI acquisition. It was hypothesized that individuals with MS would show an abnormal pattern of activity across time in specific brain areas previously hypothesized to subserve fatigue [Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci 2000;179:34-42]. Specifically, it was hypothesized that persons with MS would show a greater increase in cerebral activation across time during behavioral performance than that seen in healthy controls, which was interpreted as fatigue. No difference in performance accuracy on the mSDMT was observed, although the MS group was significantly slower than controls. Behavioral alterations indicative of fatigue in the MS group were associated with increased activation in the basal ganglia, frontal areas including superior, medial, middle and inferior regions, parietal regions (precuneus and cuneus), thalamus and the occipital lobes. These data provide direct support for the Chaudhuri and Behan model of "central" fatigue which hypothesizes a specific role of the "non-motor" functions of the basal ganglia.

Magnocellular contributions to impaired motion processing in schizophrenia

Patients with schizophrenia show impairments in motion processing, along with deficits in lower level processing primarily involving the magnocellular visual pathway. The present study investigates potential magnocellular contributions to impaired motion processing in schizophrenia using a combined neurophysiological and behavioral approach. As compared to prior motion studies in schizophrenia, thresholds were determined for both incoherent and coherent visual motion. In this study, velocity discrimination thresholds were measured for schizophrenia patients (n=14) and age-matched normal control subjects (n=16) using a staircase procedure. Early visual processing was evaluated using steady-state visual evoked potentials (ssVEP), with stimuli biased toward activation of either the magnocellular or parvocellular visual pathways through luminance contrast manipulation. Patients with schizophrenia showed poor velocity discrimination for both incoherent and coherent motion, with no significant group x task interaction. Further, when coherent motion performance was measured at individually determined incoherent motion thresholds, accuracy levels for patients were similar to controls, also indicating similarity of deficit for incoherent vs. coherent motion discrimination. Impairments in velocity discrimination correlated significantly with reduced amplitude of ssVEP elicited by magnocellular -- but not parvocellular -- selective stimuli. This study demonstrates that deficits in motion processing in schizophrenia are significantly related to reduced activation of the magnocellular visual system. Further, this study supports and extends prior reports of impaired motion processing in schizophrenia, and indicates significant bottom-up contributions to higher-order cognitive impairments.

Task switching and the measurement of "switch costs"

The measurement of "switch costs" is held to be of interest because, as is widely believed, they may reflect the control processes that are engaged when subjects switch between two (or more) competing tasks. [In task-switching experiments, the reaction time (RT) switch cost is typically measured as the difference in RT between switch and non-switch (repeat) trials.] In this report we focus on the RT switch costs that remain even after the subject has had some time to prepare for the shift of task, when the switch cost may be approximately asymptotic (so-called residual switch costs). Three experiments are presented. All three experiments used Stroop colour/word, and neutral stimuli. Participants performed the two tasks of word-reading and colour-naming in a regular, double alternation, using the "alternating runs" paradigm (R. D. Rogers & S. Monsell, 1995). The experiments were designed to test the hypothesis that RT switch costs depend on a form of proactive interference (PI) arising from the performance of a prior, competing task. A. Allport, E. A. Styles and S. Hsieh (1994) suggested that these PI effects resulted from "task-set inertia", that is, the persisting activation-suppression of competing task-sets, or competing task-processing pathways. The results confirmed the existence of long-lasting PI from the competing task as a major contributor to switch costs. Non-switch trials, used as the baseline in the measurement of switch costs, were also shown to be strongly affected by similar PI effects. However, task-set inertia was not sufficient to account for these results. The results appeared inconsistent also with all other previous models of task switching. A new hypothesis to explain these between-task interference effects was developed, based on the stimulus-triggered retrieval of competing stimulus-response (S-R) associations, acquired (or strengthened) in earlier trials. Consistent with this retrieval hypothesis, switch costs were shown to depend primarily on the S-R characteristics of the preceding task (the task that was switched from) rather than the upcoming task. Further, the effects of the other, competing task were found to persist over many successive switching trials, affecting switch costs long after the stimulus overlap (and hence the principal S-R competition) between the current tasks had been removed. Switch costs were also found to be affected by recent, item-specific experience with a given stimulus, in either the same or the competing task. Finally, the results showed that switch costs were massively affected by the ratio of the number of prior trials, in response to the same stimuli, that had implemented either the currently intended or the competing S-R mappings. None of these effects are predicted by current models of residual switch costs, which appeal to the differences in control processes assumed to be engaged in switch versus non-switch trials.

A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial

Tenidap is a novel anti-rheumatic drug that combines cytokine modulation with cyclo-oxygenase inhibition. This 24-week, multicentre, double-blind, randomized study compared the clinical efficacy, biochemical effects and safety of tenidap 120 mg/day (once daily) with diclofenac 150 mg/day (50 mg t.i.d) in the treatment of 384 patients with active rheumatoid arthritis. After 24 weeks, improvement with tenidap was significantly greater than with diclofenac for all five primary efficacy parameters, two of the four secondary efficacy parameters and 11 of the 13 Arthritis Impact Measurement Scales assessments. The superior efficacy of tenidap was apparent after 4 weeks of treatment with further improvements observed by 24 weeks. The probability of discontinuation due to lack of efficacy was significantly greater in the diclofenac group. Tenidap but not diclofenac was associated with significant, rapid and sustained reductions in C-reactive protein and serum amyloid A levels and with a significant reduction in plasma interleukin-6. The nature and frequency of side-effects were similar in the two groups as was the discontinuation rate for treatment-related safety reasons. Tenidap was associated with an equal incidence of elevated transaminases, but a higher incidence of mild (> or = 500 mg/24 h < 1500 mg/24 h) non-progressive, proteinuria of proximal tubular origin compared with diclofenac.

Histamine and Nt-methylhistamine in the circulation during intravenous infusion of histamine in normal volunteers

Plasma levels of histamine and Nt-methylhistamine were measured simultaneously by high performance liquid chromatography during the intravenous infusion of histamine acid phosphate in six normal volunteers. Progressive, dose-related increases in plasma histamine were noted, reaching a maximum value of 3.1 +/- 0.14 ng ml-1 corresponding to a maximum infusion rate of 180 ng kg-1 min-1 (means +/- SEM). Increases in plasma histamine were accompanied by a significant dose-related fall in mean diastolic blood pressure (baseline 74.0 +/- 4.4 mm Hg falling to 60.0 +/- 3.3 mm Hg at maximum infusion rate, p less than 0.001) and an increase in pulse rate (baseline 76.3 +/- 2.8 beats min-1 rising to 89.24 beats min-1 at maximum infusion rate, p less than 0.05). All subjects exhibited facial flushing, the threshold plasma histamine level for this effect being 1.3 +/- 0.15 ng ml-1 corresponding to an infusion rate of 60 ng kg-1 min-1. Elevation of plasma Nt-methylhistamine was seen in only one subject, who exhibited a level of 0.5 ng ml-1 at the highest infusion rate. These results suggest that measurements of plasma Nt-methylhistamine are unlikely to provide a useful index of histamine release into the circulation.